Accelerate Diagnostics JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Exact Sciences CEO Kevin Conroy discussed the firm's pipeline and plans for 2020 and beyond, while NanoString CEO Brad Gray talked about the company's GeoMx digital spatial profiling technology, among other presentations Wednesday. Accelerate Diagnostics Preliminary Q4 Revenues Rise 94 Percent The firm cited continued delays in getting instruments set up and running in labs, leading to less generation of consumables revenues. People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth Premium New outcomes data shows that the firm's test can help clinicians optimize antibiotic prescribing, but investment analysts have had mixed reactions. Luminex, Accelerate Diagnostics Downgraded by JP Morgan to Underweight The investment bank adjusted its December 2020 price target for Luminex's stock to $21 and for Accelerate Diagnostics' stock to $16. Dec 26, 2018 GenMark Fungal Blood Culture Test Clears FDA Aug 23, 2018 Luminex Verigene MDx Panel Speeds Up AST, Reduces Cost, Study Finds Premium Jun 15, 2017 FDA Clearance for GenMark's ePlex Intensifies Competition in Highly Plexed MDx Test Market Premium Sep 16, 2016 Sepset Biosciences Developing Sepsis Test Based on Cellular Reprogramming Signature Premium Jul 22, 2016 Speed and Accuracy Top Considerations for Lab Directors in Choosing Sepsis Dx Premium Jul 13, 2016 Accelerate Diagnostics' Pathogen ID, Antimicrobial Susceptibility Platform Moves Closer to Market Premium Jul 11, 2016 Accelerate Diagnostics Submits Molecular, Phenotypic Detection Technologies for FDA Evaluation Jan 29, 2016 District Court Dismisses Shareholders' Lawsuit Against Accelerate Diagnostics Aug 3, 2015 Accelerate Dx Posts Increase in Q2 Revenues, Net Loss Jul 1, 2015 Accelerate Dx Lands CE Mark for ID/AST System, Initiates Clinical Trial Enrollment May 11, 2015 Accelerate Dx Q1 Revenues Flat; Plans Clinical Trial for FDA Submission of Microbiology Platform Mar 23, 2015 Accelerate Dx Faces Fraud Allegations in Shareholders' Class Action Suit Mar 16, 2015 Accelerate Diagnostics Achieves ISO Certification Feb 27, 2015 Accelerate Diagnostics' 2014 Revenues Rise Sharply Feb 23, 2015 Accelerate Dx, Denver Health Medical Center Awarded $5M for Microbial MDx Development Jan 13, 2015 JP Morgan Healthcare Conference, Day Two: Thermo Fisher Scientific, Affymetrix, Danaher, Hologic, Genmark, Accelerate Diagnostics Nov 4, 2014 Accelerate Dx, CDC Collaborate on Early Detection of Antibiotic-Resistant Pathogens May 5, 2014 Accelerate Dx Q1 Revenues Slide 13 Percent May 2, 2014 Accelerate Diagnostics Completes $45M Rights Offering Apr 7, 2014 Accelerate Dx Begins $45M Rights Offering Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.